Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients
Open Access
- 1 August 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Complementary and Alternative Medicine
- Vol. 12 (1), 112
- https://doi.org/10.1186/1472-6882-12-112
Abstract
Background: Traditional Chinese medicine (TCM) is a widely applied complementary therapy for cancer patients. It can reduce the chemical drugs induced toxic effects to improve the quality of life (QOL). This study applies the highest quality of clinical trial methodology to examine the role of TCM in improving QOL of postoperative non-small-cell lung cancer patients. Methods and design: This study is a multi-center, randomized, placebo-controlled, double-blind trial. Four hundred eighty patients will be recruited into seven different research centers in China. These patients that meet the inclusion criteria will be randomized into either a treatment group or a placebo group. Each group will receive treatments of 3-weekly chemotherapy with TCM or placebo for four cycles. The primary outcome will involve the evaluation of QOL and the secondary outcome assessments will include two-year disease-free survival rate and disease-free survival. Other efficacy assessments are changes of TCM symptoms and toxicity. Side effects and safety profile of the therapy would be evaluated at the same time. The investigators expect that TCM therapy combined with chemotherapy is superior to chemotherapy solely in terms of QOL improvement and disease-free survival extension. "Intention-to-treat" analysis will include all randomized participants. Discussion: The results from the clinical trial will provide evidence for the effectiveness of chemotherapy combined with or without TCM in QOL of postoperative NSCLC patients. Trial registration: Clinical Trials.gov (Identifier: NCT01441752).Keywords
This publication has 17 references indexed in Scilit:
- Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 2011
- Use of Chinese Herbal Medicine as an Adjuvant for Cancer Treatment: A Randomized Controlled Dose-Finding Clinical Trial on Lung Cancer PatientsJournal of Cancer Therapy, 2011
- Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic reviewLung Cancer, 2009
- Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non–Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10Journal of Clinical Oncology, 2008
- Validation of the Simplified Chinese Version of the Quality of Life Instrument EORTC QLQ-LC43 for Patients with Lung CancerCancer Investigation, 2008
- Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non–small cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 2007
- A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicityAnnals of Oncology, 2007
- Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLCEuropean Journal of Cardio-Thoracic Surgery, 2005
- Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of lifeThorax, 2004
- Effects of Shakuyaku-kanzo-to on Muscle Pain from Combination Chemotherapy with Paclitaxel and CarboplatinGynecologic Oncology, 2001